Search

Several new phage therapy reviews are out: one on the pharmacological limitations of phage therapy by Anders Nilsson, one on promises and pitfalls of in vivo evolution to improve phage therapy by James Bull and colleagues, and one on explor

Phages were successfully used to treat a 41-year old's cardiac infection, which involved a cardiac implantable electronic device and aortic graft, at the German Heart Center Berlin in Berlin, Germany.

Congratulations to Dr. Minmin Yen, CEO of PhagePro, a company developing a phage cocktail as a household cholera prophylactic — she just won $10,000 in the 2019 TropMed pitch competition hosted by the American Society for Tropical Medicine

John Rex, MD (Chief Medical Officer for Wellcome Trust) has written a blog post about a new paper published by Ursula Theuretzbacher and colleagues on the global pre-clinical pipeline for antibacterials. It shows that as of May 2019, 33/407

Congratulations to Dr. Minmin Yen, CEO of PhagePro, a company developing a phage cocktail as a household cholera prophylactic — she just won $10,000 in the 2019 TropMed pitch competition hosted by the American Society for Tropical Medicine

Phages were successfully used to treat a 41-year old's cardiac infection, which involved a cardiac implantable electronic device and aortic graft, at the German Heart Center Berlin in Berlin, Germany.

Phage Futures Congress 2020 is happening Feb 5-6, 2020 in Washington, DC. Early bird pricing ends Dec 6. Use discount code 'PHAGEDIRECTORY' for an extra 10% off! Hope to see you there!

Several new phage therapy reviews are out: one on the pharmacological limitations of phage therapy by Anders Nilsson, one on promises and pitfalls of in vivo evolution to improve phage therapy by James Bull and colleagues, and one on explor

Steven Swift (Beltsville Agricultural Research Center) and colleagues have engineered a chimeric phage lysin that lyses Clostridium perfringens, an important poultry pathogen. They fused the cell wall binding domain of a C. perfringens phag

Rebecca Quinn, University of Warwick My name is Rebecca Quinn, I'm a PhD student at University of Warwick, researching phage genetics. I'm funded by the BBSRC, and under the direction of Dr Richard Puxty. I have funding for a 3 month work

Rebecca Quinn, University of Warwick My name is Rebecca Quinn, I'm a PhD student at University of Warwick, researching phage genetics. I'm funded by the BBSRC, and under the direction of Dr Richard Puxty. I have funding for a 3 month work

Karen Weynberg and Paul Jaschke of the University of Queensland and Macquarie University in Australia have published a perspective on how high-throughput phage engineering could be accomplished using biofoundries, core facilities that enabl

In collaboration with researchers at Brunel University London, a new UK synthetic biology company called CC Bio is developing phage lysins to target bacterial vaginosis caused by Gardnerella vaginalis. They've just received £250,000 in fund

Ushanandini Mohanraj (University of Helsinki) and colleagues have published a paper showing a screen they've developed to identify hypothetical phage proteins with antibacterial activity. They've used it to identify four Yersinia phage prot

Mainstream news outlets are covering antibiotic resistance as a result of the two major antibiotic resistance reports just released (which we covered last week). CBS News gets into why the system for antimicrobial development is broken. Glo

Gabriel Almeida (University of Jyvaskyla, Finland) and colleagues have published a paper showing that phages of the fish pathogen Flavobacterium columnare bind to mucus, providing new support for the 'bacteriophage adherence to mucus' (BAM)

Felix Biotechnology is a new phage company using phages to target antibiotic resistant bacteria based on their mechanism of antibiotic resistance (working with Yale University). They just won this year's Falling Walls Venture competition in

In collaboration with researchers at Brunel University London, a new UK synthetic biology company called CC Bio is developing phage lysins to target bacterial vaginosis caused by Gardnerella vaginalis. They've just received £250,000 in fund

Karen Weynberg and Paul Jaschke of the University of Queensland and Macquarie University in Australia have published a perspective on how high-throughput phage engineering could be accomplished using biofoundries, core facilities that enabl

Gabriel Almeida (University of Jyvaskyla, Finland) and colleagues have published a paper showing that phages of the fish pathogen Flavobacterium columnare bind to mucus, providing new support for the 'bacteriophage adherence to mucus' (BAM)